Original language | English |
---|---|
Article number | 624 |
Pages (from-to) | 12 |
Number of pages | 1 |
Journal | Blood |
Volume | 136 |
Issue number | Supplement 1 |
DOIs | |
Publication status | Published - 5 Nov 2020 |
Externally published | Yes |
Event | 62nd American Society of Hematology Annual Meeting and Exposition - Virtual Duration: 5 Dec 2020 → 8 Dec 2020 |
Effect of pembrolizumab (pembro) monotherapy versus brentuximab vedotin (BV) on patients (Pts) with relapsed/refractory classical Hodgkin lymphoma (R/R cHL): exploratory analysis of the randomized, phase 3 KEYNOTE-204 study by prior lines of therapy
John Kuruvilla, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A. Johnson, Laura Maria Fogliatto, Iara Goncalves, Jose de Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Neta Goldschmidt, Irina Kryachok, Naohiro Sekiguchi, Jianxin Lin, Akash Nahar, Patricia Marinello, Pier Luigi Zinzani
Research output: Contribution to journal › Meeting abstract › peer-review